Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Could This Humira Biosimilar Be a Winner for Amgen?
06:00am, Friday, 03'rd Mar 2023
This Humira biosimilar just launched in the U.S. several weeks ago.
March's 17 Ideal 2023 Barrons/Bloomberg Dividend Dogs
02:25am, Friday, 03'rd Mar 2023
Two Barron's Annual Roundtable, plus one Bloomberg Intelligence article published late January listed 99 stocks of-note for 2023; 78 of those were unduplicated US publicly-listed companies, of which 5
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
12:47pm, Thursday, 02'nd Mar 2023
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?
The 12 Best Stocks to Buy Now
04:28pm, Thursday, 23'rd Feb 2023
The lesson of the past two years: Be ready for anything. Our best stocks to buy now reflect opportunities amid an uncertain economic backdrop.
Nicholas Ward's Dividend Growth Portfolio: January 2023 Review
02:35am, Thursday, 23'rd Feb 2023
My dividend income rose by 9.56% on a y/y basis during January. My portfolio's value rose by approximately 6.9%.
Want More Reliable Dividend Income? Buy This Dividend King.
07:30am, Wednesday, 22'nd Feb 2023
This big pharma company possesses a deep drug portfolio and pipeline.
Want Growing Passive Income? Buy This Dow Jones Stock
06:05am, Wednesday, 22'nd Feb 2023
This big pharma company possesses a solid drug pipeline.
How Are Biotech ETFs Reacting to Q4 Earnings Releases?
03:48pm, Tuesday, 21'st Feb 2023
The latest earnings from some of the big biotech players came in at mixed this reporting season.
Best Stocks To Buy Now? 2 Dow Jones Stocks To Watch In 2023
02:07pm, Friday, 17'th Feb 2023
Are these the best Dow Jones Industrial Average stocks to buy in 2023?
2 Market-Beating Dividend Stocks to Buy With $500
07:45am, Thursday, 16'th Feb 2023
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
5 Stocks In The Dividend Growth Sweet Spot
04:08pm, Wednesday, 15'th Feb 2023
Finding companies with a high initial yield and rapid dividend growth is difficult. I present my criteria for finding such companies. At present, there are 16 companies meeting my initial screening re
Final Trades: Devon Energy, Broadcom, Keysight & more
02:22pm, Wednesday, 15'th Feb 2023
The "Halftime Report" traders give their top picks to watch for the second half.
5 Least-Hurt Biotech ETFs of the Last Week
02:18pm, Wednesday, 15'th Feb 2023
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Amgen sees about $56 billion in demand for mega bond deal
12:00pm, Wednesday, 15'th Feb 2023
Amgen Inc. has attracted about $55.7 billion of investor orders on Wednesday for its mega bond deal, signaling strong demand for financing tied to its roughly $28 billion acquisition of Dublin-based
